Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response-Reference-Cited by-同舟云学术

Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response

Published:2015-04 Issue:4 Volume:42 Page:767-777
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Surace Laura,Lysenko Veronika,Fontana Andrea Orlando,Cecconi Virginia,Janssen Hans,Bicvic Antonela,Okoniewski Michal,Pruschy Martin,Dummer Reinhard,Neefjes Jacques,Knuth Alexander,Gupta Anurag,van den Broek Maries

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference66 articles.

1. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat. Med.,2007

2. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis;Auphan;Science,1995

3. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation;Baelder;J. Immunol.,2005

4. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway;Basu;Int. Immunol.,2000

5. C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens;Baudino;Proc. Natl. Acad. Sci. USA,2014

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement is increased in treatment resistant rectal cancer and modulates radioresistance.;Cancer Letters;2024-09

2. An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascade;Biomedicine & Pharmacotherapy;2024-08

3. Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors;Cancer Communications;2024-06-05

4. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors;Critical Reviews in Oncology/Hematology;2024-06

5. Discovering the Radiation Biomarkers in the Plasma of Total-Body Irradiated Leukemia Patients;Radiation Research;2024-05-08